Our global Life Sciences and Health Care team reports on current and evolving trends that are shaping the future of the industry. Read More
Every complex discovery program can face a unique set of challenges. Read More
As Massachusetts’s current 10-year, $1 billion life science program sunsets in 2018, Governor Baker plans to add an additional $500 million in life science program funding. Read More
In an expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life sciences companies can curtail risk by allocating time and money in a capital Read More
New York has announced some serious developments and may threaten Boston and San Francisco as the top spots in the biotech community. Read More
In this podcast you'll learn how the R+D Tax Credit benefits the life sciences industry. Read More
Involving public affairs early during the development and commercialization process of a new asset is critical to success when demonstrating value to payers and policy makers. Learn how to communicate value during this... Read More
Impact 2020 is the culmination of nearly nine months of meetings, discussions, interviews, and online and in-person focus-sessions with a diverse set of life sciences stakeholders about the future of the industry. What... Read More
Download Attachment
Four themes dominated discussions during the Impact 2020 strategic assessment. Each one leads to a set of recommendations to ensure the industry’s success into the future. Read More
Download Attachment
Presentation from Vikas Goyal, SR One, at MassBio's October 2014 Bio Entrepreneur Bootcamp. Read More
Download Attachment